发布求助
文献互助 智能选刊 最新文献

European Journal of Clinical Microbiology最新文献

筛选
英文 中文
Visceral leishmaniasis in a patient seropositive for HIV. 一名HIV血清阳性患者的内脏利什曼病。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014266
J Alvar, J Verdejo, A Osuna, R Nájera
{"title":"Visceral leishmaniasis in a patient seropositive for HIV.","authors":"J Alvar, J Verdejo, A Osuna, R Nájera","doi":"10.1007/BF02014266","DOIUrl":"https://doi.org/10.1007/BF02014266","url":null,"abstract":"","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"604-6"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014266","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14561317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Pharmacokinetics and tissue penetration of orally administered pefloxacin. 口服培氟沙星的药代动力学和组织渗透。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014239
J M Webberley, J M Andrews, J P Ashby, A McLeod, R Wise
{"title":"Pharmacokinetics and tissue penetration of orally administered pefloxacin.","authors":"J M Webberley,&nbsp;J M Andrews,&nbsp;J P Ashby,&nbsp;A McLeod,&nbsp;R Wise","doi":"10.1007/BF02014239","DOIUrl":"https://doi.org/10.1007/BF02014239","url":null,"abstract":"<p><p>The pharmacokinetics of the quinolone pefloxacin were determined following a 400 mg oral dose given to each of six male volunteers. Concentrations were determined in serum and urine by high-performance liquid chromatography, and in cantharidin-induced inflammatory fluid by a microbiological assay. The mean peak serum level of 6.6 micrograms/ml was attained rapidly 0.8 h after administration. The mean serum elimination half-life was 11.6 h. Inflammatory fluid was penetrated quickly with a mean peak level of 3.9 micrograms/ml occurring at 2.4 h. Pefloxacin was excreted in the urine as the parent compound and its two metabolites, norfloxacin and pefloxacin N-oxide (24 h urinary recovery being 8.0%, 12.0% and 13.1% respectively of the dose). This study suggests that a twice or possibly once daily dosage may be sufficient to treat systemic infections caused by susceptible pathogens. Once daily dosing should be sufficient for urinary tract infections.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"521-4"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014239","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14605021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Fast identification of adenovirus 40/41 in infants with enteritis. 婴儿肠炎腺病毒40/41的快速鉴定。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014267
R Wigand
{"title":"Fast identification of adenovirus 40/41 in infants with enteritis.","authors":"R Wigand","doi":"10.1007/BF02014267","DOIUrl":"https://doi.org/10.1007/BF02014267","url":null,"abstract":"","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"606-7"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014267","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13968100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid. 苯氧甲基青霉素和头孢地诺辛在扁桃体组织和扁桃体表面液体中的浓度。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014240
A Strömberg, U Friberg, O Cars
{"title":"Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid.","authors":"A Strömberg,&nbsp;U Friberg,&nbsp;O Cars","doi":"10.1007/BF02014240","DOIUrl":"https://doi.org/10.1007/BF02014240","url":null,"abstract":"<p><p>Thirty patients who underwent elective tonsillectomy were given phenoxymethylpenicillin (0.8 g) or cefadroxil (1 g) at different times before operation. The concentrations of the antibiotics were analysed in serum, tonsillar tissue, fluid from the surface of the tonsils, and mixed saliva. The concentrations in tonsillar tissue for both drugs were much lower than the corresponding serum concentrations. This apparently low tissue accessibility could be ascribed to the limited intracellular penetration of beta-lactam antibiotics. For both antibiotics the concentrations in the tonsillar surface fluid were higher than the levels in the tissue and well above the minimal inhibitory concentrations for streptococci. This was not due to antibiotics in saliva but probably a result of leakage from the interstitial fluid. Inability to reach active concentrations of phenoxymethylpenicillin or cefadroxil at the site of infection does not therefore seem to be a probable cause for relapse after treatment of streptococcal tonsillitis.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"525-9"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014240","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14255552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074. 比较两种新型口服头孢菌素代谢产物RO 19-5247和RO 15-8074的体外活性。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014247
K E Aldridge, D D Schiro, C V Sanders
{"title":"Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.","authors":"K E Aldridge,&nbsp;D D Schiro,&nbsp;C V Sanders","doi":"10.1007/BF02014247","DOIUrl":"https://doi.org/10.1007/BF02014247","url":null,"abstract":"<p><p>A total of 629 clinical strains of gram positive and gram negative bacteria were tested for their susceptibility to RO 19-5247, RO 15-8074, and other antimicrobial agents. Both RO 19-5247 and RO 15-8074 had good activity against strains of Enterobacteriaceae; however, resistance was found among some strains of Enterobacter, Citrobacter, Klebsiella and Morganella spp. Both compounds showed moderate to poor active against Acinetobacter spp., Pseudomonas aeruginosa, staphylococci and Streptococcus faecalis. Against strains of Haemophilus influenzae, Neisseria gonorrhoeae, Gardnerella vaginalis, Streptococcus pneumoniae and streptococci (not enterococci), each compound was highly active in vitro. RO 19-5247 and RO 15-8074 had comparable activity to cotrimoxazole, ceftazidime and ceftizoxime. Each new compound had considerably better activity then did cefaclor and amoxicillin/potassium clavulanate.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"564-9"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14560708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Bacteria in bile of patients with bile duct inflammation. 胆管炎症患者胆汁中的细菌。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014251
K Kosowski, E Karczewska, A Kasprowicz, J Andziak, P B Heczko
{"title":"Bacteria in bile of patients with bile duct inflammation.","authors":"K Kosowski,&nbsp;E Karczewska,&nbsp;A Kasprowicz,&nbsp;J Andziak,&nbsp;P B Heczko","doi":"10.1007/BF02014251","DOIUrl":"https://doi.org/10.1007/BF02014251","url":null,"abstract":"<p><p>Bile samples taken intraoperatively from 100 patients with three different bile system diseases were subjected to bacteriological analysis. Statistically significant differences between the types of aerobic and anaerobic bacteria present in the bile were found.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"575-8"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014251","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14561310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Bacterial vaginosis: microbiological and clinical findings. 细菌性阴道病:微生物学和临床表现。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014242
E Holst, B Wathne, B Hovelius, P A Mårdh
{"title":"Bacterial vaginosis: microbiological and clinical findings.","authors":"E Holst,&nbsp;B Wathne,&nbsp;B Hovelius,&nbsp;P A Mårdh","doi":"10.1007/BF02014242","DOIUrl":"https://doi.org/10.1007/BF02014242","url":null,"abstract":"<p><p>A prospective study was performed involving 101 women who consecutively attended a primary health care unit for complaints of genital malodour and/or abnormal vaginal discharge. Bacterial vaginosis was diagnosed in 34 women on the basis of four diagnostic criteria: vaginal pH greater than 4.7, homogeneous vaginal discharge, a positive amine test and clue cells. The sensitivity of these criteria was greater than 90% except for homogeneous discharge (82%). Their specificity was greater than 90% except for vaginal pH greater than 4.7 (46%); a specificity of 87% could have been achieved by using the criterion for vaginal pH greater than or equal to 5.0. There was a strong association between diagnosis of bacterial vaginosis and the concomitant occurrence of Gardnerella vaginalis, Mobiluncus spp. and Bacteroides spp. There was no difference between women with or without bacterial vaginosis as regards contraception methods (except for use of an intrauterine device), age at first intercourse, or earlier episodes of vaginal discharge. Sexual transmission of the predominant bacteria was not supported by data collected from the male consorts.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"536-41"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014242","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14624555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 62
Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem. 亚胺培南成功治疗复发性脑脓肿及脑脓肿。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014252
J A Carton, F Perez, J A Maradona, F J Mendez
{"title":"Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem.","authors":"J A Carton,&nbsp;F Perez,&nbsp;J A Maradona,&nbsp;F J Mendez","doi":"10.1007/BF02014252","DOIUrl":"https://doi.org/10.1007/BF02014252","url":null,"abstract":"<p><p>Imipenem was successfully used to treat a case of subdural empyema complicated by multiple cerebral abscesses, in which surgery and therapy with other antibiotics had previously failed. Imipenem concentrations in serum, cerebrospinal fluid and the cerebral abscess were much higher than the MICs for the infecting organisms, qualifying this antibiotic as an effective option in therapy of suppurative intracranial infections.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"578-80"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014252","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14030174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100. 口服头孢菌素 BMY-28100 的体外活性和β-内酰胺酶稳定性。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014246
M Hiraoka, S Masuyoshi, K Tomatsu, M Inoue, S Mitsuhashi
{"title":"In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.","authors":"M Hiraoka, S Masuyoshi, K Tomatsu, M Inoue, S Mitsuhashi","doi":"10.1007/BF02014246","DOIUrl":"10.1007/BF02014246","url":null,"abstract":"<p><p>BMY-28100 was compared with cephalexin, cefaclor, cefixime, and cefteram and found to be more active than the reference cephalosporins against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus faecalis, and Clostridium difficile. BMY-28100 was the next most active, after cefteram, against Streptococcus pyogenes and Streptococcus pneumoniae. Against gram-negative bacteria, BMY-28100 showed similar activity to that of cefaclor. The antimicrobial activity of BMY-28100, including bactericidal activity, against Staphylococcus aureus was less affected by penicillinase-production than was that of cefaclor. BMY-28100 was more stable than cefaclor against various types of penicillinases, especially against the penicillinase from Staphylococcus aureus.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"559-63"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014246","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14625317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892. 新1-碳霉素LY163892 -内酰胺酶水解及抑制研究。
European Journal of Clinical Microbiology Pub Date : 1987-10-01 DOI: 10.1007/BF02014248
R N Jones, A L Barry
{"title":"Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.","authors":"R N Jones,&nbsp;A L Barry","doi":"10.1007/BF02014248","DOIUrl":"https://doi.org/10.1007/BF02014248","url":null,"abstract":"<p><p>A novel 1-carbacephem, LY163892, was determined to be more stable to plasmid-mediated beta-lactamases than cefaclor. Chromosomal-mediated Type Ia and IVc enzymes destroyed LY163892 at rates ranging from 16 to 93% that of nitrocefin. LY163892 showed minimal ability to inhibit beta-lactamases other than Type Ia (P99).</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 5","pages":"570-1"},"PeriodicalIF":0.0,"publicationDate":"1987-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02014248","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14625318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信